Video Latest - ecancer

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada

12 Dec 2014

Best of ASH 2014

Prof Simon Rule, Prof Antonio Palumbo, Prof Peter Hillmen, Prof Gert Ossenkoppele

8 Dec 2014

ASH 2014: Highlights in CLL from ASH 2014

Prof Peter Hillmen, Prof Clemens Wendtner, Prof Ulrich Jäger

8 Dec 2014

Hope for avoiding chemo in patients with Hodgkins lymphoma

Prof Massimo Federico - University of Modena and Reggio Emilia, Modena, Italy

8 Dec 2014

ASH 2014: Highlights in mantle cell lymphoma

Prof Steven Le Gouill and Prof Simon Rule

8 Dec 2014

Paediatric leukaemia treatment regimens lead to improved outcomes in adolescents and young adults

Dr Wendy Stock - University of Chicago, Chicago, USA

7 Dec 2014

Children with rare leukaemia have better-than-expected outcomes after tailored treatment

Dr Brent Wood - Seattle Children's Hospital, Seattle, USA

7 Dec 2014

ASH 2014: Expert discussion on the latest in AML

Prof Alan Burnett and Prof Sergio Amadori

7 Dec 2014

ASH 2014: Expert discussion on the latest in CLL

Prof John Gribben and Prof Stephan Stilgenbauer

7 Dec 2014

Daratumumab plus standard treatment improves outcomes in relapsed, hard-to-treat multiple myeloma in phase I study

Prof Marivi Mateos - University Hospital of Salamanca, Salamanca, Spain

7 Dec 2014

Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA

7 Dec 2014

Predicting the relapse of acute myeloid leukaemia with genetic screening

Dr Elaine Mardis - University of Washington, Washington, USA

2 Dec 2014

Video